Clinical Trials
24 trialsTrop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
iCaRe2
University of Nebraska
ANTARES
Instituto do Cancer do Estado de São Paulo
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
AYAConnect
UNC Lineberger Comprehensive Cancer Center
MOLTHYSO
Institut Bergonié
EARN
Washington University School of Medicine
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
AMPLIFY
University of Alabama at Birmingham
ACROPOLI
SOLTI Breast Cancer Research Group
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
CAPABLE-IT
Istituti Clinici Scientifici Maugeri SpA
AcSé
UNICANCER
OPTI-DOSE
University Medical Center Groningen
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Zhujiang Hospital
Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors
University of Alabama at Birmingham
Spectroscopy With Surface Coils and Decoupling
Memorial Sloan Kettering Cancer Center
Rapamycin With Grapefruit Juice for Advanced Malignancies
University of Chicago
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Rutgers, The State University of New Jersey